SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Eli Lilly's stock price shot up by 2.89% on a massive trading volume of 21.27 billion, signaling strong investor interest.

The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...

It’s understandable. When the path ahead is unclear, the instinct is to pause. To wait.

AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...